Skip to main content

Table 7 Final T and N stages of the cases in the neoadjuvant group detected by different imaging modalities

From: The additive role of dynamic contrast-enhanced and diffusion-weighted MR imaging in preoperative staging of breast cancer

Size (T) SM DCE-MRI MRI-DWI Pathology
T0 2/13 (15.3%) 7/13 (53.8%) 8/13 (61.5%) 7/13 (53.8%)
T1 5/13(38.4%) 1/13 (7.7%) 0/13 1/13 (7.7%)
T2 6/13 (46.1%) 5/13 (38.4%) 5/13 (38.4%) 4/13 (30.7%)
T3 0/13 0/13 0/13 0/13
T4 0/13 0/13 0/13 1/13 (7.7%)
Lymph node (N) SM DCE-MRI MRI-DWI Pathology
Nx 1/13 (7.7%) 1/13 (7.7%) 0/13 0/13
N0 8/13 (61.5%) 8/13 (61.5%) 9/13 (69.2%) 8/13 (61.5%)
N1 4/13 (30.7%) 4/13 (30.7%) 4/13 (30.7%) 2/13 (15.3%)
N2 0/13 0/13 0/13 5/13 (38.4%)